Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

IHE vs FHLC overlap: 41% of top holdings shared

Bottom line

How much do IHE and FHLC overlap?

41% of their top holdings overlap by weight. 5 securities appear in both funds' top 25, making up 57.6% of IHE's assets and 30.9% of FHLC's. They share a meaningful core but differ in the rest of the portfolio.

FHLC holds far more positions (337 vs 59), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

IHEFHLC
Weight overlap (top 25)41%
Shared holdings5
Weight in shared holdings57.6%30.9%
Total positions59337
Expense ratio0.37%0.084%
Holdings as ofJun 30, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Holdings IHE and FHLC have in common

Holding% of IHE% of FHLCOverlap
Johnson & Johnson22.44%8.93%8.93%
Eli Lilly And Company22.25%13.35%13.35%
Merck & Co., Inc.4.55%4.66%4.55%
Bristol-myers Squibb Company4.37%1.93%1.93%
Pfizer Inc.3.96%2.06%2.06%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in IHE

  1. BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 6.24%
  2. Royalty Pharma Plc — 4.34%
  3. Viatris Inc. — 4.22%
  4. Zoetis Inc. — 3.73%
  5. Jazz Pharmaceuticals Public Limited Company — 3.45%
  6. Elanco Animal Health Incorporated — 2.81%
  7. Axsome Therapeutics, Inc. — 2.42%
  8. Corcept Therapeutics Incorporated — 1.90%
  9. Ligand Pharmaceuticals Incorporated — 1.45%
  10. Definium Therapeutics Inc — 1.39%
  11. Liquidia Corp — 1.28%
  12. Indivior Pharmaceuticals, Inc. — 1.14%
  13. Crinetics Pharmaceuticals Inc — 0.90%
  14. Organon & Co. — 0.81%
  15. Edgewise Therapeutics Inc — 0.70%

Only in FHLC

  1. AbbVie Inc — 6.42%
  2. UnitedHealth Group Inc — 5.44%
  3. Thermo Fisher Scientific Inc — 3.09%
  4. Amgen Inc — 3.00%
  5. Abbott Laboratories — 2.66%
  6. Gilead Sciences Inc — 2.34%
  7. CVS Health Corp — 1.92%
  8. Intuitive Surgical Inc — 1.82%
  9. Danaher Corp — 1.80%
  10. Vertex Pharmaceuticals Inc — 1.76%
  11. Stryker Corp — 1.62%
  12. Medtronic PLC — 1.59%
  13. McKesson Corp — 1.52%
  14. Elevance Health Inc — 1.19%
  15. Regeneron Pharmaceuticals Inc — 1.15%

Asset mix

Asset typeIHEFHLC
Stocks99.9%99.7%
Cash & short-term funds6.3%0.2%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Country mix

CountryIHEFHLC
US96.4%96.5%
GB4.3%0.5%
IE3.8%2.2%
CA1.4%0.2%
BM—0.2%
SG0.2%—
KY0.2%—
CH—0.1%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do IHE and FHLC overlap?
About 41% by weight. 5 securities appear in both funds' top 25 holdings; they make up 57.6% of IHE's assets and 30.9% of FHLC's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do IHE and FHLC have in common?
The largest shared holdings are Eli Lilly And Company, Johnson & Johnson, Merck & Co., Inc., Pfizer Inc., Bristol-myers Squibb Company.
Should I own both IHE and FHLC?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, IHE or FHLC?
FHLC is broader, with 337 positions versus 59 for IHE. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.